Literature DB >> 4891888

The potentiating effect of rheumatoid arthritis serum in the immediate phase of nephrotoxic nephritis.

J N McCormick, J Day, C J Morris, A G Hill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4891888      PMCID: PMC1579046     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  14 in total

1.  INHIBITION OF COMPLEMENT FIXATION BY HUMAN SERUM. II. THE ACTIVITY OF A GAMMA-LM GLOBULIN AND RHEUMATOID FACTOR IN COMPLEMENT FIXATION REACTIONS.

Authors:  R HEIMER; F M LEVIN; M F KAHN
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

2.  PROTECTION OF A COMPLEMENT-SENSITIVE ENZYME SYSTEM BY RHEUMATOID FACTOR.

Authors:  J S DAVIS; A J BOLLET
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

3.  A STUDY OF RHEUMATOID FACTOR TITERS IN PATIENTS RECEIVING PLASMA AND GAMMA GLOBULIN.

Authors:  M WALLER; F MULLINAX; E C TOONE; L THURMAN
Journal:  Arthritis Rheum       Date:  1965-02

4.  Transfusion studies in rheumatoid arthritis.

Authors:  J HARRIS; J H VAUGHAN
Journal:  Arthritis Rheum       Date:  1961-02

5.  Studies of aggregated gamma-globulin. I. Sedimentation, electrophoretic and anticomplementary properties.

Authors:  C L CHRISTIAN
Journal:  J Immunol       Date:  1960-01       Impact factor: 5.422

6.  Isothiocyanate compounds as fluorescent labeling agents for immune serum.

Authors:  J L RIGGS; R J SEIWALD; J H BURCKHALTER; C M DOWNS; T G METCALF
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

7.  Course and prognosis in rheumatoid arthritis.

Authors:  J J DUTHIE; P E BROWN; J D KNOX; M THOMPSON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

8.  Inhibition of complementary lysis by rheumatoid sera.

Authors:  J A Romeyn; D M Bowman
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

9.  The effect of rheumatoid factors and of antigobulins of immune hemolysis in vivo.

Authors:  M E KAPLAN; J H JANDL
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

10.  EXPERIMENTAL GLOMERULONEPHRITIS. IV. PARTICIPATION OF COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  E UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  13 in total

1.  IgM rheumatoid factor in congenital syphilis: associations with clinical and laboratory findings.

Authors:  M P Meyer; D W Beatty
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  A study of complement fixation by rheumatoid factor using a haemolytic assay system.

Authors:  M M Taylor-Upsahl; P M Johnson; O J Mellbye; J B Natvig
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

3.  Immune complexes in rheumatoid synovitis: a mixed staining immunofluorescence study.

Authors:  L Bonomo; A Tursi; D Trizio; U Gillardi; F Dammacco
Journal:  Immunology       Date:  1970-04       Impact factor: 7.397

4.  Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus.

Authors:  D Koffler; V Agnello; R I Carr; H G Kunkel
Journal:  Am J Pathol       Date:  1969-09       Impact factor: 4.307

5.  Mesangiocapillary (membranoproliferative) glomerulonephritis and rheumatoid arthritis.

Authors:  H C Ting; F Wang
Journal:  Br Med J       Date:  1977-01-29

6.  In situ immune complex formation in the mouse glomerulus: reactivity with human IgM rheumatoid factor and the effect on subsequent immune complex deposition.

Authors:  P M Ford; I Kosatka
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG.

Authors:  R D Rossen; M A Reisberg; J T Sharp; W N Sucki; F X Schloeder; L L Hill; G Eknoyan
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Glomerular lesions induced in the rabbit by physicochemically altered homologous IgG.

Authors:  F Cavalot; M Miyata; A Vladutiu; V Terranova; S Dubiski; R Burlingame; E Tan; J Brentjens; F Milgrom; G Andres
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

9.  The role of IgM rheumatoid factor in experimental immune vasculitis.

Authors:  M Floyd; J T Tesar
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

10.  Complement fixation by rheumatoid factor.

Authors:  K Tanimoto; N R Cooper; J S Johnson; J H Vaughan
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.